Literature DB >> 7801762

Local recurrence of soft tissue sarcoma a risk factor for late metastases. 379 patients followed for 0.5-20 years.

C S Trovik1, H C Bauer.   

Abstract

We performed a retrospective analysis of 379 adult patients treated for soft tissue sarcoma. None had metastasis at the time of diagnosis and all were treated surgically. Patients who developed metastatic disease before the local recurrence were excluded. The 8-year metastasis-free survival rate in the group of 261 patients with local tumor control was 0.72, compared to 0.67 in the 118 patients with local recurrence (P 0.2). Multiple regression analysis showed that high-grade malignancy and large tumor size were risk factors for metastases. Local recurrence was not a risk factor. However, when patients with small and/or low-grade tumors were analyzed separately, local recurrence emerged as a risk factor. In this group of patients, the 8-year survival rate was 0.87 for those with local control and 0.64 for those with local recurrence (P 0.004). Local recurrence appears to be a risk factor for the development of late metastases in patients who otherwise have a low risk of metastases.

Entities:  

Mesh:

Year:  1994        PMID: 7801762     DOI: 10.3109/17453679409000913

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  5 in total

1.  Case series. Soft-tissue sarcoma of the foot.

Authors:  L Daniel Latt; Robert E Turcotte; Marc H Isler; Cynthia Wong
Journal:  Can J Surg       Date:  2010-12       Impact factor: 2.089

2.  Clinical features, treatment, and outcome in 102 adult and pediatric patients with localized high-grade synovial sarcoma.

Authors:  H Al-Hussaini; D Hogg; M E Blackstein; B O'Sullivan; C N Catton; P W Chung; A M Griffin; D Hodgson; S Hopyan; R Kandel; P C Ferguson; J S Wunder; A A Gupta
Journal:  Sarcoma       Date:  2011-04-14

3.  High incidence of metastatic disease in primary high grade and large extremity soft tissue sarcomas treated without chemotherapy.

Authors:  Benedikt Leidinger; Thomas Heyse; Andreas Schuck; Horst Buerger; Philipp Mommsen; Thomas Bruening; Susanne Fuchs; Georg Gosheger
Journal:  BMC Cancer       Date:  2006-06-18       Impact factor: 4.430

4.  Should tumor depth be included in prognostication of soft tissue sarcoma?

Authors:  Anders Rydholm; Pelle Gustafson
Journal:  BMC Cancer       Date:  2003-05-26       Impact factor: 4.430

Review 5.  Plastic Surgery in the Multimodal Treatment Concept of Soft Tissue Sarcoma: Influence of Radiation, Chemotherapy, and Isolated Limb Perfusion on Plastic Surgery Techniques.

Authors:  Nicolai Kapalschinski; Ole Goertz; Kamran Harati; Maximilian Kueckelhaus; Jonas Kolbenschlag; Marcus Lehnhardt; Tobias Hirsch
Journal:  Front Oncol       Date:  2015-12-01       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.